Atlas FDA

QVCAD System (Version 3.3)

FDA premarket approval P150043/S001 · decided 2017-12-14

Approval details

PMA number
P150043
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
QVCAD System (Version 3.3)
Generic name
Analyzer, medical image
Applicant
Qview Medical, Inc.
Date received
2017-06-14
Decision date
2017-12-14
Days to decision
183 days
Decision code
APPR
Product code
MYN
Advisory committee
Radiology
Expedited review
No
Location
Los Altos, CA
Statement
Approval for QVCAD System (Version 3.3). The QVCAD System is indicated for use as an aid to the reader during screening procedures in searching images of female breasts produced by the somo•v and Invenia Automated Breast Ultrasound Systems (screening mammography BIRADS® Assessment Category 1 or 2, and BI-RADS Composition/Density c or d) to detect mammography-occult lesions in regions not known to have suspicious findings. The indicators produced by the QVCAD System are not intended to be used fo

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.